World Investment Advisors significantly increased its holdings in Procter & Gamble (NYSE:PG) by 15.9% during the fourth quarter of 2025, now owning shares valued at over $15 million. This move signals the firm's confidence in the consumer goods giant's long-term potential, citing strong brand recognition and consistent financial performance. The increased stake is viewed as a positive indicator by institutional investors, suggesting continued growth for P&G despite economic uncertainties.

This article provides financial information for Public Storage (GETTEX:PUP), specifically focusing on its "Total debt per share" metric. It appears to be a financial data page from TradingView, offering an overview of the company's financials for investors and analysts.

Faruqi & Faruqi, LLP is reminding investors of New Era Energy & Digital (NUAI) about the June 1, 2026 deadline to seek lead plaintiff status in a securities class action lawsuit. The lawsuit alleges that New Era made false and misleading statements regarding its Texas Critical Data Centers project, engaged in a fraudulent scheme to avoid environmental responsibilities for oil and gas wells, and that these actions caused its stock to drop after reports from Fuzzy Panda Research and the New Mexico Attorney General's lawsuit. Investors who purchased NUAI securities between November 6, 2024, and December 29, 2025, and suffered losses are encouraged to contact the law firm.

Revvity, Inc. (RVTY) is a health sciences solutions provider valued at $10 billion. The company is expected to announce its fiscal first-quarter earnings for 2026 soon, with analysts projecting a diluted EPS of $1.02, a 1% increase year-over-year. Despite consistent EPS beats, RVTY stock has underperformed the S&P 500 and the Health Care Select Sector SPDR ETF in the past year, partly due to fears surrounding new global tariffs.

Faruqi & Faruqi, LLP is reminding investors of Soleno Therapeutics (SLNO) about the May 5, 2026 deadline to seek the role of lead plaintiff in a federal securities class action lawsuit. The firm is investigating potential claims that Soleno made false or misleading statements regarding the safety and commercial viability of its drug DCCR, particularly concerning its Phase 3 clinical trial program and undisclosed safety risks. These allegations follow a critical report from Scorpion Capital LLC, a patient death, and revelations that the report impacted DCCR's launch trajectory, leading to significant stock price declines.

Faruqi & Faruqi, LLP is reminding investors of Snowflake (NYSE: SNOW) who purchased securities between June 27, 2023, and February 28, 2024, about the April 27, 2026, deadline to seek lead plaintiff status in a federal securities class action. The lawsuit alleges that Snowflake and its executives made misleading statements regarding the negative impact of product efficiency gains, Iceberg Tables, and tiered storage pricing on consumption and revenues. This led to a significant stock price drop following the disclosure of financial results and the CEO's retirement announcement on February 28, 2024.

Robeco Institutional Asset Management B.V. reduced its stake in Cardinal Health, Inc. by 4.9% during the fourth quarter of 2025, selling 45,452 shares. This reduction signals a potential shift in market sentiment, though Cardinal Health remains an attractive investment for many institutional investors. The firm's updated holdings now represent approximately 0.38% of Cardinal Health's outstanding shares.

Ocular Therapeutix (OCUL) recently presented its retinal pipeline at major ophthalmology meetings, keeping investors focused on the phase 3 Axpaxli program. The company plans to pursue an NDA for Axpaxli based on year one SOL-1 data, making conference updates critical for understanding filing timelines and capital needs. While the current narrative projects strong revenue growth and a high fair value, some analysts present a more cautious outlook due to the heavy reliance on Axpaxli's trial outcomes.

This article provides a brief financial update for Huntington Bancshares Incorporated (HU3) on the Hannover Stock Exchange. It specifically mentions "Net income from continuing operations" alongside market data from ICE Data Services and reference data from FactSet. The content is very short and mainly focuses on the availability of this specific financial metric.

Kessler Topaz Meltzer & Check, LLP has filed class action lawsuits against PayPal Holdings, Inc. (PYPL) on behalf of investors who purchased common stock between February 8, 2024, and February 2, 2026. The lawsuits allege material misstatements and omissions regarding PayPal's revenue outlook and growth, leading to a significant stock drop on February 3, 2026. Investors have until April 20, 2026, to seek lead plaintiff status in the case.